标题
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer
作者
关键词
-
出版物
DRUG METABOLISM REVIEWS
Volume 44, Issue 2, Pages 148-172
出版商
Informa UK Limited
发表日期
2012-04-12
DOI
10.3109/03602532.2011.638303
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients
- (2010) C Montagut et al. BRITISH JOURNAL OF CANCER
- Optimal Delivery of Cytotoxic Chemotherapy for Colon Cancer
- (2010) Laura Raftery et al. CANCER JOURNAL
- Susceptibility Genetic Variants Associated With Colorectal Cancer Risk Correlate With Cancer Phenotype
- (2010) Anna Abulí et al. GASTROENTEROLOGY
- Levels of Rectal Mucosal Polyamines and Prostaglandin E2 Predict Ability of DFMO and Sulindac to Prevent Colorectal Adenoma
- (2010) Patricia A. Thompson et al. GASTROENTEROLOGY
- Primary Prevention of Colorectal Cancer
- (2010) Andrew T. Chan et al. GASTROENTEROLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability
- (2010) Marisa Donada et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Activation of signal pathways and the resistance to anti-EGFR treatment in colorectal cancer
- (2010) Jiezhong Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
- (2010) Diane Lauren Reidy et al. JOURNAL OF CLINICAL ONCOLOGY
- High Antimetastatic Efficacy of MEN4901/T-0128, a Novel Camptothecin Carboxymethyldextran Conjugate
- (2010) Huaiyu Ma et al. JOURNAL OF SURGICAL RESEARCH
- Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab
- (2010) E F Dunn et al. ONCOGENE
- Metastatic Colorectal Cancer: From Improved Survival to Potential Cure
- (2010) David J. Gallagher et al. ONCOLOGY
- Malignant colorectal polyps
- (2010) Luis Bujanda WORLD JOURNAL OF GASTROENTEROLOGY
- Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
- (2010) Janja Ocvirk WORLD JOURNAL OF GASTROENTEROLOGY
- Inhibitor of Apoptosis (IAP) Proteins: Novel Insights into the Cancer-Relevant Targets for Cell Death Induction
- (2009) Simone Fulda ACS Chemical Biology
- FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level: an exploratory cohort of the GERCOR OPTIMOX1 study
- (2009) B. Chibaudel et al. ANNALS OF ONCOLOGY
- A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)
- (2009) M. Ychou et al. ANNALS OF ONCOLOGY
- KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy
- (2009) Ahmad D. Siddiqui et al. ANNALS OF SURGICAL ONCOLOGY
- PTEN status in advanced colorectal cancer treated with cetuximab
- (2009) F V Negri et al. BRITISH JOURNAL OF CANCER
- Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer
- (2009) Nadine A. Jackson et al. CANCER
- Vandetanib with FOLFIRI in patients with advanced colorectal adenocarcinoma: results from an open-label, multicentre Phase I study
- (2009) Mark P. Saunders et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines
- (2009) Sara Nannizzi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
- (2009) M. M. Bertagnolli et al. Cancer Prevention Research
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- A Phase I, Pharmacokinetic and Pharmacodynamic Study on Vorinostat in Combination with 5-Fluorouracil, Leucovorin, and Oxaliplatin in Patients with Refractory Colorectal Cancer
- (2009) M. G. Fakih et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
- (2009) Peter Kozuch et al. Clinical Colorectal Cancer
- Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III
- (2009) Jane D. Robertson et al. Clinical Colorectal Cancer
- Overview of the Molecular Bases of Resistance to Chemotherapy in Liver and Gastrointestinal Tumours
- (2009) J. Marin et al. CURRENT MOLECULAR MEDICINE
- Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention
- (2009) Nathaniel S. Rial et al. Essays in Biochemistry
- Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature
- (2009) MY Merl et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
- (2009) Eva Martinez-Balibrea et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study
- (2009) Benoist Chibaudel et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- Complete Mesocolic Excision With Central Vascular Ligation Produces an Oncologically Superior Specimen Compared With Standard Surgery for Carcinoma of the Colon
- (2009) Nicholas P. West et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- Vorinostat and bortezomib exert synergistic antiproliferative and proapoptotic effects in colon cancer cell models
- (2009) T. M. Pitts et al. MOLECULAR CANCER THERAPEUTICS
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- The anti-proliferative potency of celecoxib is not a class effect of coxibs
- (2008) Susanne Schiffmann et al. BIOCHEMICAL PHARMACOLOGY
- Management of early rectal cancer
- (2008) M. G. Tytherleigh et al. BRITISH JOURNAL OF SURGERY
- Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
- (2008) Uroš Potočnik et al. CANCER GENETICS AND CYTOGENETICS
- FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
- (2008) Saima Sharif et al. CANCER INVESTIGATION
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
- (2008) Frank L. Meyskens et al. Cancer Prevention Research
- Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer
- (2008) Antonio Jimeno et al. Clinical & Translational Oncology
- Prediction of Broad Spectrum Resistance of Tumors towards Anticancer Drugs
- (2008) T. Efferth et al. CLINICAL CANCER RESEARCH
- Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer
- (2008) G. Folprecht et al. CLINICAL CANCER RESEARCH
- A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy
- (2008) A. Gradilone et al. CURRENT CANCER DRUG TARGETS
- An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
- (2008) F. Caponigro et al. EUROPEAN JOURNAL OF CANCER
- The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status
- (2008) Rodrigo Jover et al. EUROPEAN JOURNAL OF CANCER
- Recombinant Factor VIIa in the Management of Pulmonary Hemorrhage Associated With Metastatic Choriocarcinoma
- (2008) Matthew J. Wheater et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Wild-TypeBRAFIs Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
- (2008) Federica Di Nicolantonio et al. JOURNAL OF CLINICAL ONCOLOGY
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
- (2008) M. Okabe et al. MOLECULAR CANCER THERAPEUTICS
- Synthesis, Transport and Pharmacokinetics of 5′-Amino Acid Ester Prodrugs of 1-β-d-Arabinofuranosylcytosine
- (2008) Yongbing Sun et al. MOLECULAR PHARMACEUTICS
- Diagnosis and Management of Peritoneal Carcinomatosis Arising From Adenocarcinoma of the Colon and Rectum
- (2008) Richard E. Royal et al. SEMINARS IN ONCOLOGY
- Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer
- (2008) Laurent Poincloux et al. SURGICAL ONCOLOGY-OXFORD
- Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
- (2007) Richard F.A. Logan et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started